Parkinson’s Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing Plan

Parkinson’s Disease Medication Adherence Scale: Conceptualization, Scale Development, and Clinimetric Testing Plan

BackgroundMedication adherence is a crucial component in the management of patients with chronic diseases needing a long-term pharmacotherapy. Parkinson’s disease (PD) is a chronic, degenerative disease with complex drug treatment that poses challenging barriers to patient adherence. The adoption of...

Full description

Bibliographic Details
Main Authors: Michelle H. S. Tosin, Christopher G. Goetz, Dharah P. C. F. Bispo, Henrique B. Ferraz, Marco Antonio A. Leite, Deborah A. Hall, Glenn T. Stebbins, Beatriz Guitton R. B. Oliveira
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Aging Neuroscience
Subjects:
scale development
measurement
psychometrics (MeSH)
medication adherence (MeSH)
Parkinson’s disease
Online Access:https://www.frontiersin.org/articles/10.3389/fnagi.2022.900029/full

Internet

https://www.frontiersin.org/articles/10.3389/fnagi.2022.900029/full

Similar Items